A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...

GSK is investing up to $800 million to double the size and capacity of its production site in Marietta, Pennsylvania, the company said Thursday. Through the addition of two new facilities ...

MARIETTA, Pa. — Hundreds of millions of dollars and hundreds of new jobs are coming to Lancaster County. Vaccine manufacturer GSK announced Thursday it will invest $800 million to expand its ...

This expansion will double the size and capacity of the Marietta site,” said GSK. Regis Simard, President Global Supply Chain, GSK, said: “This landmark investment will establish Marietta as ...

Marietta site leader for GSK, said during Thursday’s announcement. GSK expects to begin construction immediately on the project, which includes a new 270,000-square-foot-facility for research ...

Despite the rise of a vaccine skeptic in the campaign of US presidential election winner Donald Trump, GSK CEO Emma Walmsley ...

GSK has stopped (PDF) development of one of the lead programs from its $2.1 billion Affinivax takeover, axing a phase 2 pneumococcal 24-valent vaccine candidate for adults in favor of a ...